WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-10 08:54 am Sale | 2023-04-28 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -13,340,377 (Position Closed) | Filing |
| 2023-02-06 2:53 pm Sale | 2022-12-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | WELLINGTON MANAGEMENT GROUP LLP | 13,340,377 8.700% | -3,999,210 (-23.06%) | Filing |
| 2022-02-04 09:21 am Sale | 2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | WELLINGTON MANAGEMENT GROUP LLP | 17,339,587 10.590% | -4,313,962 (-19.92%) | Filing |
| 2021-02-04 09:45 am Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | WELLINGTON MANAGEMENT GROUP LLP | 21,653,549 13.530% | -124,152 (-0.57%) | Filing |